Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial. Peltz G, Jansson LM, Adeniyi-Jones S, Cohane C, et al. J Perinatol 2022 Aug 27. pii: 10.1038/s41372-022-01487.

Read + Share

Amedeo Smart

Independent Medical Education

Peltz G, Jansson LM, Adeniyi-Jones S, Cohane C, et al. Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial. J Perinatol 2022 Aug 27. pii: 10.1038/s41372-022-01487.
PMID: 36030327